 |
|
|
 |
|
|
(20:39:43)
NoName enters the chatroom. ...
(11:7:33)
NoName leaves the chatroom ... ...
(11:7:4)
NoName enters the chatroom. ...
(17:22:3)
NoName enters the chatroom. ...
(17:53:47)
NoName enters the chatroom. ...
click here to open the chat window...
There are 0 people chatting right now. |
|
| |
|
|
|
|
| Adverts: Discovery and Technology Create New Therapies in Reproductive Medicine |
|
 Anonymous writes "Greystone Associates Analyzes Evolving Therapeutic Landscape
(Amherst, NH) – The convergence of target-specific biological drugs, formulation science, and patient-friendly delivery technology are creating therapeutic opportunities that will have a significant impact on the practice of female reproductive medicine. This evolution in care is occurring at a time when women in virtually every age group are struggling to cope with real or perceived medical conditions. From the side effects of hormone replacement therapy to the life-style driven increase in the incidence of HPV and infertility, women are seeking answers to their medical needs from a healthcare industry that has been sending hopeful, albeit sometimes confusing, messages.
With the increasing availability of drugs that improve therapeutic outcomes and in some cases address previously untreatable conditions, opportunities for participants in the reproductive medicine sector are starting to emerge. Recombinant proteins that produce powerful metabolic responses are replacing small-molecule drugs. Novel formulation strategies and delivery technologies are contributing to growth prospects by reducing dosing frequency, minimizing patient administration requirements and improving compliance. These developments will lead to strong growth in industrialized regions, as a growing number of women in these countries seek therapeutic solutions to gender-specific conditions.
These findings are contained in a new and comprehensive report. The report – Reproductive Medicine: Emerging Therapeutics, Expanding Opportunities - contains in-depth analysis of the drugs, pipeline candidates, technology, and market participants that are shaping the future of female reproductive medicine.
More information is available at
http://www.greystoneassociates.org
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology assessment.
Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates
"
|
|
Posted on Monday, October 09 @ 15:07:19 GMT by mantra |
|
|
|
|
| |
|
| No Comments Allowed for Anonymous, please register |
|
|
|
|
|
All information is intended for your information only and is not a substitute for medical advice or treatment for specific medical conditions. Please seek prompt medical care from your physician on any health issues. Please read our user agreement before you proceed.
Copyright © 1999-2007 MedicalMantra Information Systems Pvt. Ltd. All rights reserved.
|
